Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanz Family Office appears to be a private family office and investment vehicle associated with the Nanz family of Stuttgart, Germany. Publicly available information indicates that it acts as an investor rather than as an operating biotech, pharmaceutical, or healthcare company. It has shown participation in at least one healthtech financing round, including Neteera's Series B, but there is no evidence that it develops therapeutics, owns a clinical pipeline, or commercializes healthcare products directly. Based on currently available sources, it should be characterized as a private investment entity with selective exposure to healthcare and healthtech opportunities rather than a life sciences operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanz Family Office.